Larsen CP - Search Results

1

Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.

Thompson P, Badell IR, Lowe M, Turner A, Cano J, Avila J, Azimzadeh A, Cheng X, Pierson RN 3rd, Johnson B, Robertson J, Song M, Leopardi F, Strobert E, Korbutt G, Rayat G, Rajotte R, Larsen CP, Kirk AD. Thompson P, et al. Among authors: larsen cp. Am J Transplant. 2012 Jul;12(7):1765-75. doi: 10.1111/j.1600-6143.2012.04031.x. Epub 2012 Mar 28. Am J Transplant. 2012. PMID: 22458586 Free PMC article.

2

CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.

Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, Hendrix R, Pearson TC. Larsen CP, et al. Transplantation. 1996 Jan 15;61(1):4-9. doi: 10.1097/00007890-199601150-00002. Transplantation. 1996. PMID: 8560571

3

CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.

Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ, Larsen CP. Pearson TC, et al. Among authors: larsen cp. Transplantation. 1996 Apr 15;61(7):997-1004. doi: 10.1097/00007890-199604150-00002. Transplantation. 1996. PMID: 8623206

4

The CD40 pathway in allograft rejection, acceptance, and tolerance.

Larsen CP, Pearson TC. Larsen CP, et al. Curr Opin Immunol. 1997 Oct;9(5):641-7. doi: 10.1016/s0952-7915(97)80043-x. Curr Opin Immunol. 1997. PMID: 9368772 Review.

5

IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.

Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG. Konieczny BT, et al. Among authors: larsen cp. J Immunol. 1998 Mar 1;160(5):2059-64. J Immunol. 1998. PMID: 9498741

6

Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade.

Elwood ET, Larsen CP, Cho HR, Corbascio M, Ritchie SC, Alexander DZ, Tucker-Burden C, Linsley PS, Aruffo A, Hollenbaugh D, Winn KJ, Pearson TC. Elwood ET, et al. Among authors: larsen cp. Transplantation. 1998 Jun 15;65(11):1422-8. doi: 10.1097/00007890-199806150-00002. Transplantation. 1998. PMID: 9645796

7

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.

Triemer HL, Pearson TC, Odom KL, Larsen CP. Triemer HL, et al. Among authors: larsen cp. Clin Transplant. 2000 Aug;14(4 Pt 2):413-20. doi: 10.1034/j.1399-0012.2000.14041002.x. Clin Transplant. 2000. PMID: 10946781

8

FasL is important in costimulation blockade-resistant skin graft rejection.

Trambley J, Lin A, Elwood E, Bingaman AW, Lakkis F, Corbascio M, Pearson TC, Larsen CP. Trambley J, et al. Among authors: larsen cp. Transplantation. 2001 Feb 27;71(4):537-43. doi: 10.1097/00007890-200102270-00009. Transplantation. 2001. PMID: 11258433

9

Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.

Bingaman AW, Ha J, Durham MM, Waitze SY, Tucker-Burden C, Cowan SR, Pearson TC, Larsen CP. Bingaman AW, et al. Among authors: larsen cp. Transplantation. 2001 Oct 15;72(7):1286-92. doi: 10.1097/00007890-200110150-00018. Transplantation. 2001. PMID: 11602857

10

Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.

Ha J, Bingaman AW, Durham MM, Pearson TC, Larsen CP. Ha J, et al. Among authors: larsen cp. Transpl Immunol. 2001 Oct;9(1):13-7. doi: 10.1016/s0966-3274(01)00043-0. Transpl Immunol. 2001. PMID: 11680567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters